ARID5A and glioblastoma: Using the GBM and LGG datasets from the GEPIA database for online survival analysis, we found that the expression of ARID5A was negatively correlated with the prognoses of LGG (Figure 1B) and GBM (Figure 1C), and the higher the expression level was, the worse the prognosis was.